Anticoagulation in Patients with Chronic Kidney Disease.

Am J Nephrol · 2024 · PMC10994631 · PMID 38035566

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

An exploratory analysis in patients with CrCl >95 mL/min showed a trend toward lower efficacy with rivaroxaban (HR 1.47, 95% CI: 0.81–2.68) and edoxaban (HR 1.36, 95% CI: 0.88–2.10) in preventing stroke/SE [ 60 , 62 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.